Enhertu Injection 100 mg Price & Side Effects

 Enhertu (trastuzumab deruxtecan) is a medication used to treat HER2-positive breast cancer, which is a type of cancer that overexpresses the HER2 protein. It works by delivering a chemotherapy drug directly to the HER2-positive cancer cells, causing them to die.

Enhertu is typically administered as an intravenous (IV) infusion over a period of several hours. The recommended dose of Enhertu is 5.4 mg/kg (up to a maximum of 600 mg) every three weeks, but the actual dosage and treatment duration may vary depending on the patient's individual factors, including their weight, overall health, and response to treatment.

Like all medications, Enhertu can have potential side effects. Some of the more common ones include nausea, vomiting, diarrhea, and fatigue. More serious side effects may include heart problems, lung problems, and blood disorders. It is important to discuss any potential side effects or concerns with your healthcare provider before starting treatment with Enhertu.

As for the cost of Enhertu, this can vary depending on several factors, including the dosage, the frequency of treatment, and the patient's insurance coverage. As an AI language model, I don't have access to real-time pricing information for medications or medical products, but it is important to discuss the cost and any potential assistance programs with your healthcare provider or pharmacist.